Nature Medicine | Spoonful of Medicine

Anemia drug recalled amid safety concerns in dialysis patients

After less than a year on the market, a long-acting anemia drug called Omontys (peginesatide), a once-monthly injection used by people with chronic kidney disease, was recalled over the weekend, after US regulators received 19 reports of severe allergic reactions, including some deaths. Shares of Affymax, the Palo Alto, California–based company behind the product, were down 85% today on the news. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE